Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 25.01.2022 at 12:00 PM CET
Settings

Settings

Goto Application

1. WO2022000374 - COVID-19 VIRUS INHIBITOR

Publication Number WO/2022/000374
Publication Date 06.01.2022
International Application No. PCT/CN2020/099753
International Filing Date 01.07.2020
IPC
A61K 31/7088 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7088Compounds having three or more nucleosides or nucleotides
A61P 31/14 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
14for RNA viruses
C12N 15/113 2010.1
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
15Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
09Recombinant DNA-technology
11DNA or RNA fragments; Modified forms thereof
113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
A61K 35/17 2015.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
14Blood; Artificial blood
17Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
Applicants
  • 上海嘉慷生物工程有限公司 SHANGHAI JIAKANG BIOLOGICAL ENGINEERING CO., LTD. [CN]/[CN]
Inventors
  • 徐以兵 XU, Yibing
  • 寿鑫 SHOU, Xin
  • 朱珍芳 ZHU, Zhenfang
Agents
  • 杭州华宸联名知识产权代理事务所(特殊普通合伙) HANGZHOU HUACHEN JOINT INTELLECTUAL PROPERTY AGENCY (SPECIAL GENERAL PARTNERSHIP)
Priority Data
Publication Language Chinese (zh)
Filing Language Chinese (ZH)
Designated States
Title
(EN) COVID-19 VIRUS INHIBITOR
(FR) INHIBITEUR DU VIRUS COVID-19
(ZH) 一种COVID-19病毒抑制剂
Abstract
(EN) A COVID-19 virus inhibitor, at least comprising miRNA represented by SEQ ID NO. 1-SEQ ID NO. 12. As a preferred solution, the miRNA described above use exosomes secreted by NK cells activated by means of IL-21 as a carrier.
(FR) L'invention concerne un inhibiteur du virus COVID-19, comprenant au moins un microARN (miARN) représenté par les séquences SEQ ID NO 1 à SEQ ID NO. 12. En tant que solution préférée, le miARN décrit ci-dessus utilise des exosomes sécrétés par des cellules tueuses naturelles activées par IL -21 en tant que support.
(ZH) 一种COVID-19病毒抑制剂,其至少包含SEQ ID NO.1~SEQ ID NO.12所示的miRNA。作为优选的方案,上述miRNA以经IL-21激活的NK细胞分泌的外泌体为载体。
Latest bibliographic data on file with the International Bureau